Biopharma Manufacturing Pharma Pharmaceutical manufacturing 
Fierce Pharma
JULY 12, 2023
A new triumvirate of biopharma bigwigs is in line to reign over one of the industry’s top trade groups. | The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has unveiled the upcoming lineup for its CEO leadership team over the next two years.
Pharmaceutical Technology
JULY 29, 2022
As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges. Manufacturing agility: Index score 6.5/10. R&D ecosystem - Index score 6.54/10.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
SEPTEMBER 14, 2023
The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharma manufacturing site. This increases renewable energy capacity to the national gas grid.
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. Some pharmaceutical companies are increasing their R&D spending to increase product numbers.
pharmaphorum
DECEMBER 28, 2022
M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.
pharmaphorum
AUGUST 4, 2022
In particular, for the pharmaceutical industry, these talent shortages bring about a host of difficult challenges. This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Training and development. Embrace mobile learning.
Pharmaceutical Technology
SEPTEMBER 13, 2022
The acquisition will expand the international solutions portfolio of AmerisourceBergen aiding in advancing its position as a preferred partner for biopharmaceutical manufacturers. This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes.
Expert insights. Personalized for you.
204 
Let's personalize your content